Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes
NCT00899223 · View on ClinicalTrials.gov ↗
Study Summary
As one of the nation's largest cooperative cancer treatment groups, the Alliance for Clinical Trials in Oncology (Alliance) is in a unique position to organize a Leukemia Tissue Bank. The member institutions diagnose hundreds of patients with leukemia or myelodysplastic syndrome each year, and uniformly treat these patients with chemotherapy regimens. The Alliance offers centralized data management for the clinical history, the classification of the leukemia and myelodysplastic syndrome, cytogenetics, flow cytometric analysis, treatment and follow-up. The highly skilled health care providers at each member institution are familiar with obtaining informed consent, completing data questionnaires and shipping specimens. There currently exists a central processing facility where samples are prepared for a variety of cellular and molecular studies. Hence, the patient resources, the health care providers, and a processing facility for a Leukemia Tissue Bank are all in place. What is needed, however, and is addressed in the current protocol, is a formal mechanism to procure bone marrow, blood and normal tissue from patients with hematologic malignancies who are to be enrolled on Alliance (Cancer and Leukemia Group B \[CALGB\]) treatment studies.
Conditions Studied
Interventions
- OTHER biologic sample preservation procedure
Study Locations (20)
Illinois
- Illinois CancerCare - Bloomington — Bloomington
- St. Joseph Medical Center — Bloomington
- Illinois CancerCare - Canton — Canton
- University of Illinois Cancer Center — Chicago
- Veterans Affairs Medical Center - Chicago Westside Hospital — Chicago
- University of Chicago Cancer Research Center — Chicago
- Eureka Community Hospital — Eureka
California
- Camino Medical Group - Treatment Center — Mountain View
- — Pismo Beach
- Naval Medical Center - San Diego — San Diego
- UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco
Florida
- Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital — Fort Lauderdale
- Ella Milbank Foshay Cancer Center at Jupiter Medical Center — Jupiter
- CCOP - Mount Sinai Medical Center — Miami Beach
- Florida Hospital Cancer Institute at Florida Hospital Orlando — Orlando
Delaware
- Tunnell Cancer Center at Beebe Medical Center — Lewes
- CCOP - Christiana Care Health Services — Newark
District of Columbia
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center — Washington D.C.
- Washington Cancer Institute at Washington Hospital Center — Washington D.C.
Connecticut
- Helen and Harry Gray Cancer Center at Hartford Hospital — Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 1996-05 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00899223
The ClinicalTrials.gov registry entry for NCT00899223 describes a study currently listed as active not recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 147 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 3 conditions, with Acute Leukemia appearing as the primary indexed condition, and to 1 intervention — of which biologic sample preservation procedure is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT00899223 reports 20 study locations spanning 6 distinct geographic areas — top geographies include Illinois, California, Florida. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT00899223 about?
NCT00899223 is a clinical study titled "Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes". As one of the nation's largest cooperative cancer treatment groups, the Alliance for Clinical Trials in Oncology (Alliance) is in a unique position to organize a Leukemia Tissue Bank. The member institutions diagnose hundreds of patients with leukemia or myelodysplastic syndrome each year, and unifo...
What is the current status of trial NCT00899223?
This trial is currently active not recruiting. The enrollment target is 1,500 participants. The study started on 1996-05.
What conditions does trial NCT00899223 study?
This clinical trial studies the following conditions: Acute Leukemia, Myelodysplasia, Chronic Leukemia. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT00899223?
The interventions under investigation include: biologic sample preservation procedure (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT00899223?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 147 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT00899223 being conducted?
This trial has 20 study locations across California, Connecticut, Delaware, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.